Estimating changes in antibiotic consumption in the USA with the introduction of doxycycline post-exposure prophylaxis

Lancet Microbe. 2024 Jan;5(1):e9. doi: 10.1016/S2666-5247(23)00314-2. Epub 2023 Oct 23.

Authors

Kirstin I Oliveira Roster¹, Yonatan H Grad²

Affiliations

¹ Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
² Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Harvard University, Boston, MA 02115, USA. Electronic address: ygrad@hsph.harvard.edu.

PMID: 37883986
DOI: 10.1016/S2666-5247(23)00314-2

No abstract available

Publication types

Letter
Research Support, U.S. Gov't, P.H.S.
Research Support, N.I.H., Extramural

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Antibiotic Prophylaxis
Doxycycline* / therapeutic use
Post-Exposure Prophylaxis
Time Factors
United States / epidemiology

Substances

Anti-Bacterial Agents
Doxycycline

Grants and funding